专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07631450B2 Advertising display for portable structure 失效
标题翻译：广告显示便携式结构
公开(公告)号：US07631450B2
公开(公告)日：2009-12-15
申请号：US11557603
申请日：2006-11-08
申请人： Terrance Popowich , Jeremy Miller , Ian Hessel , Richard Porter , Walter Wolanczyk
发明人： Terrance Popowich , Jeremy Miller , Ian Hessel , Richard Porter , Walter Wolanczyk
IPC分类号： A47G1/06
CPC分类号： G09F15/0043 , G06Q30/02 , G06Q30/0251 , G09F15/0012 , G09F15/0018 , G09F19/00 , G09F19/22
摘要： Frame assemblies (10) for displaying sheets of advertising on portable structures such as portable toilets are adapted for durability and ease of use and maintenance. In various embodiments a frame assembly according to the invention may comprise a cover (32) for protecting sheets of advertising, a backing (34) for supporting the sheets, and various types of novel frame members (12). In other embodiments frame assemblies according to the invention can comprise sets (72, 74) of mating frame members (12), the frame members held together, when advertising is installed, at least partly by the interaction of flanges or other portions of the mating members.
摘要翻译：用于在诸如便携式厕所的便携式结构上显示广告片的框架组件（10）适于耐用性和易于使用和维护。在各种实施例中，根据本发明的框架组件可以包括用于保护广告片的盖子（32），用于支撑片材的背衬（34）和各种类型的新颖的框架构件（12）。在其它实施例中，根据本发明的框架组件可以包括配合框架构件（12）的组件（72,74），当安装广告时，框架构件保持在一起，至少部分地由凸缘或配合的其它部分的相互作用会员

2. 发明申请

US20060199828A1 Pyrazine-2-carboxyamide derivatives 审中-公开
标题翻译：吡嗪-2-甲酰胺衍生物
公开(公告)号：US20060199828A1
公开(公告)日：2006-09-07
申请号：US11366007
申请日：2006-02-28
申请人： Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
发明人： Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
IPC分类号： A61K31/506 , A61K31/4965 , A61K31/497 , C07D403/02 , C07D417/02 , C07D409/02
CPC分类号： C07D401/12 , C07D241/26 , C07D401/14 , C07D403/02 , C07D403/12 , C07D403/14 , C07D409/02 , C07D417/02 , C07D417/12 , C07D417/14
摘要： The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I) wherein R1, R2 and R3 are as defined in the specification. These compounds are useful for the treatment of CNS disorders.
摘要翻译：本发明涉及式（I）的新的吡嗪2-甲酰胺衍生物，其中R 1，R 2和R 3 3定义如上所定义在规范中。这些化合物可用于治疗CNS疾病。

3. 发明申请

US20060160816A1 Pirazino(AZA) indole derivatives 审中-公开
标题翻译：吡嗪嗪（AZA）吲哚衍生物
公开(公告)号：US20060160816A1
公开(公告)日：2006-07-20
申请号：US11374157
申请日：2006-03-14
申请人： David Adams , Jon Bentley , James Davidson , Matthew Dunction , Richard Porter
发明人： David Adams , Jon Bentley , James Davidson , Matthew Dunction , Richard Porter
IPC分类号： A61K31/498 , C07D487/04
CPC分类号： C07D487/04
摘要： Chemical compounds of formula (I): and pharmaceutically acceptable salts and addition compounds and prodrugs thereof are useful in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes inspidus, and sleep apnea.
摘要翻译：式（I）的化合物及其药学上可接受的盐和加成化合物及其前药可用于治疗，特别是用于治疗中枢神经系统疾病; 损害中枢神经系统; 心血管疾病; 胃肠道疾病; 糖尿病，睡眠呼吸暂停。

4. 发明申请

US20050054686A1 Imidazole derivatives 失效
标题翻译：咪唑衍生物
公开(公告)号：US20050054686A1
公开(公告)日：2005-03-10
申请号：US10926670
申请日：2004-08-26
申请人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
发明人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
IPC分类号： C07D401/06 , C07D401/14 , A61K31/4439 , A61K31/4164 , A61K31/4178 , C07D43/02
CPC分类号： C07D401/06 , C07D401/14
摘要： The present invention relates to imidazole derivatives of formula I wherein R1, R2, R3, R4, X, Y and R are described hereinabove, or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition comprising the imidazole derivatives of formula I, a process for preparing a compound of formula I, and a method of treating or preventing acute and/or chronic neurological disorder comprising administering to a patient in need of such treatment and/or prevention a therapeutically effective amount of said pharmaceutical composition. These disorders include Alzheimer's disease. These disorders also include mild cognitive impairment.
摘要翻译：本发明涉及式I的咪唑衍生物，其中R 1，R 2，R 3，R 4，X，Y和R如上所述，或其药学上可接受的盐。本发明还涉及药物组合物，其包含式I的咪唑衍生物，制备式I化合物的方法，以及治疗或预防急性和/或慢性神经障碍的方法，包括对需要这种治疗的患者施用和/或预防治疗有效量的所述药物组合物。这些疾病包括阿尔茨海默氏病。这些疾病也包括轻度认知障碍。

5. 发明授权

US07765388B2 Interrupt verification support mechanism 失效
标题翻译：中断验证支持机制
公开(公告)号：US07765388B2
公开(公告)日：2010-07-27
申请号：US10664055
申请日：2003-09-17
申请人： Geoff Barrett , Richard Porter
发明人： Geoff Barrett , Richard Porter
IPC分类号： G06F9/00 , G06F9/44
CPC分类号： G06F9/3836 , G06F9/30032 , G06F9/327 , G06F9/328 , G06F9/3857 , G06F9/3861 , G06F9/3885
摘要： The present invention relates to a device for an interrupt verification support mechanism and the method for operating said device comprising a processor and an input for external interrupt requests or interrupt pseudo-instructions communicatively coupled to the processor. The method comprises the steps of processing at least one actual instruction in the processor in an instruction pipeline, and if an external interrupt request is received by the processor, the actual instruction is replaced with the pseudo-instruction. Pursuant to the method, instructions are concurrently processed in the processor in an instruction pipeline with several stages. In the instruction pipeline, instructions are processed by an instruction fetch stage, an instruction decode stage, an instruction issue stage, an execute stage and a result write-back stage. Thereby, interrupt requests are only processed at the fetch stage of the instruction pipeline. The device of an interrupt support mechanism and the method for operating said device provides the advantage a simplification of interrupt verification.
摘要翻译：本发明涉及一种用于中断验证支持机制的装置和用于操作所述装置的方法，该装置包括处理器和用于通信地耦合到处理器的外部中断请求或中断伪指令的输入。该方法包括以下步骤：在指令流水线中处理处理器中的至少一个实际指令，如果处理器接收到外部中断请求，则用伪指令替换实际指令。根据该方法，在具有多个级的指令流水线中，在处理器中同时处理指令。在指令流水线中，通过指令提取阶段，指令解码阶段，指令发布阶段，执行阶段和结果回写阶段来处理指令。因此，中断请求仅在指令流水线的提取阶段处理。中断支持机制的装置和操作所述装置的方法提供了简化中断验证的优点。

6. 发明申请

US20060160857A1 Thiazole-4-carboxyamide derivatives 失效
标题翻译：噻唑-4-甲酰胺衍生物
公开(公告)号：US20060160857A1
公开(公告)日：2006-07-20
申请号：US11328879
申请日：2006-01-10
申请人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
发明人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
IPC分类号： A61K31/445 , A61K31/454 , A61K31/426 , A61K31/427 , C07D417/02
CPC分类号： C07D277/42 , C07D417/12 , C07D417/14
摘要： The present invention is concerned with novel thiazole 4-carboxyamide derivatives of the general formula (I) and with methods for the preparation thereof, which compounds are useful as metabotropic glutamate receptor antagonists: wherein R1 to R4 are as defined in the specification.
摘要翻译：本发明涉及通式（I）的新型噻唑-4-甲酰胺衍生物及其制备方法，该化合物可用作代谢型谷氨酸受体拮抗剂：其中R 1至R' SUP> 4 如说明书中所定义。

7. 外观设计

USD429051S Portable hoist 失效
公开(公告)号：USD429051S
公开(公告)日：2000-08-01
申请号：US81337
申请日：1997-12-30
申请人： Richard Porter
设计人： Richard Porter

8. 发明申请

US20060030559A1 Diazole derivatives 审中-公开
标题翻译：二唑衍生物
公开(公告)号：US20060030559A1
公开(公告)日：2006-02-09
申请号：US11141547
申请日：2005-05-31
申请人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
发明人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
IPC分类号： A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/4439 , C07D417/14 , C07D403/14 , C07D413/14
CPC分类号： C07D401/06 , C07D401/14
摘要： The present invention relates to diazole derivatives of the general formula wherein A, E, R1, R2 and R3 are as defined in application and pharmaceutical compositions containing them. The invention also relates to use of such compounds for the treatment of diseases mediated by the metabotropic glutamate receptors (mGluR), such as anxiety, chronic and acute pain, protection against liver damage, urinary incontinence, obesity, Fragile-X and autism, Alzheimer's disease, epilepsy, schizophrenia, ischemia, Huntington's chorea, amyotrophic lateral sclerosis (ALS), dementia caused by AIDs, and Parkinson's disease.
摘要翻译：本发明涉及以下通式的二唑衍生物：其中A，E，R 1，R 2和R 3如申请中所定义和含有它们的药物组合物。本发明还涉及这种化合物用于治疗由代谢型谷氨酸受体（mGluR）介导的疾病的用途，例如焦虑，慢性和急性疼痛，防止肝损伤，尿失禁，肥胖，脆性-X和自闭症，阿尔茨海默病疾病，癫痫，精神分裂症，局部缺血，亨廷顿舞蹈病，肌萎缩性侧索硬化（ALS），AID引起的痴呆和帕金森病。

9. 发明授权

US06938564B2 Method and system for concentrating chemical granules around a planted seed 有权
标题翻译：在种植种子周围浓缩化学颗粒的方法和系统
公开(公告)号：US06938564B2
公开(公告)日：2005-09-06
申请号：US10801656
申请日：2004-03-17
申请人： Larry M. Conrad , Richard Porter
发明人： Larry M. Conrad , Richard Porter
IPC分类号： A01C7/06 , A01C7/20 , A01C7/00 , A01C9/00
CPC分类号： A01C7/206 , A01C7/06
摘要： A system or method for dispensing seeds and chemical granules, in which chemical granules are dispensed through a granule tube into a seed dispensing tube, where the granule tube is connected to the seed dispensing tube at a location above a lower opening of the seed dispensing tube, and where the lower opening of the seed dispensing tube is covered with a brush. A seed is dispensed through the seed dispensing tube. The brush holds chemical granules within the seed dispensing tube such that chemical granules accumulate within the seed dispensing tube, and the brush allows a seed and accumulated chemical granules to pass through the lower opening when the seed is dispensed via the seed dispensing tube.
摘要翻译：用于分配种子和化学颗粒的系统或方法，其中通过颗粒管将化学颗粒分配到种子分配管中，其中颗粒管在种子分配管的下部开口上方的位置连接到种子分配管，并且种子分配管的下部开口被刷子覆盖。通过种子分配管分配种子。刷子将化学颗粒保持在种子分配管内，使得化学颗粒积聚在种子分配管内，并且当通过种子分配管分配种子时，刷允许种子和累积的化学颗粒通过下部开口。

10. 发明申请

US20050009878A1 Imidazole derivatives 有权
标题翻译：咪唑衍生物
公开(公告)号：US20050009878A1
公开(公告)日：2005-01-13
申请号：US10874948
申请日：2004-06-23
申请人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
发明人： Bernd Buettelmann , Simona Ceccarelli , Georg Jaeschke , Sabine Kolczewski , Richard Porter , Eric Vieira
IPC分类号： A61K31/4178 , A61K31/4439 , A61P25/00 , A61P25/22 , C07D401/06 , C07
CPC分类号： C07D401/06 , A61K31/4178 , A61K31/4439
摘要： The present invention relates to imidazole derivatives of the general formula wherein R1, R2, R3 and R4 are as defined hereinabove. This invention also relates to the compound's pharmaceutically acceptable salt and processes for the preparation thereof. These compounds can be used for the manufacture of pharmaceutical compositions for the treatment and prevention of mGluR5 receptor mediated disorders. These compounds are useful, inter alia, in the treatment or prevention of acute and/or chronic neurological disorders such as psychosis, epilepsy, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficit disorders, as well as chronic and acute pain.
摘要翻译：本发明涉及以下通式的咪唑衍生物：其中R 1，R 2，R 3和R 4如上所定义。本发明还涉及该化合物的药学上可接受的盐及其制备方法。这些化合物可用于制备用于治疗和预防mGluR5受体介导的病症的药物组合物。这些化合物尤其用于治疗或预防急性和/或慢性神经障碍如精神病，癫痫，精神分裂症，阿尔茨海默病，认知障碍和记忆缺陷障碍以及慢性和急性疼痛。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式